Prostate Cancer Model

Prostate cancer is one of the primary causes of cancer-related morbidity and mortality worldwide and requires the generation of efficient research models to enhance our knowledge of its pathophysiology and advance treatment approaches. This chapter provides an extensive review of the models used in prostate cancer research, including everything from intricate in vivo models to developing humanized models and in vitro systems. It will emphasize the roles of various models in elucidating disease mechanisms, testing therapeutic strategies, and advancing personalized medicine. The chapter begins with an examination of the epidemiology and prevalence of prostate cancer, providing an overview of the disease’s important statistics and risk factors. Comprehending these facets is crucial in placing the various research models in their proper context. The chapter then explores the molecular drivers and subtypes of prostate cancer. It describes the genetic and epigenetic changes that propel the advancement of the disease, especially those linked to prostate cancer that is androgen-dependent and resistant to castration. Interpreting the usefulness and significance of experimental models requires an understanding of this molecular context. Applications of in vitro models, including patient-derived organoids and known cell lines, in drug development and mechanistic research are discussed. The advantages and limitations of these models are emphasized by focusing on their role in mimicking human disease and providing personalized treatment approaches. The chapter delves deeper into in vivo models, such as patient-derived xenografts (PDX) and genetically modified mouse models. Studying tumor behavior, development, and therapeutic responses in a more intricate biological setting is made possible by these models. Also covered are the challenges and factors related to these models. A review of mathematical modeling of prostate cancer evolution and response to treatment is presented, illustrating the ways in which computational models advance our knowledge of tumor dynamics and therapeutic optimization. These models provide important insights into the course of the disease, resistance to treatment, and personalized treatment strategies. Overall, this chapter emphasizes how various modeling techniques might be combined to further the study of prostate cancer. Through the integration of genetic insights, experimental models, and epidemiological data, this work underscores the continued efforts to enhance patient outcomes and focus future research endeavors in this area.